Medical Research
Cll Global Research Foundation
HOUSTON, TX
Total revenue
$3.1M
Total expenses
$3.5M
Net assets
$9.4M
Grants received
$6.9M
62 grants
EIN
880517430
Tax year
2024
Mission
To accelerate progress toward the control and cure of chronic lymphocytic leukemia (CLL).
Programs
2 programs
ALLIANCE: The US/European Alliance for the Therapy of CLL (Alliance) is comprised of 25 individuals from the United States and Europe, representing the world's experts in CLL research. The members are divided into working groups focusing on one of five big ideas in CLL research (new drugs, gene/vaccine therapy, genetics, CLL-stromal interactions, transplant/immune reconstitution). The Alliance was built to encourage close collaboration within and among working groups. As such, meetings are held to bring investigators together to collaborate.
EDUCATION: CLL Global Research Foundation hosts annual interactive patient education events where CLL patients learn about emerging therapies, current treatment options and support resources from leading CLL experts. Both virtual and in-person events were held in 2024.
Financials
FY 2024
Revenue
Expenses
People
12 listed
Sam Margaret Pace
CDO
$169K
35 hrs/wk
William Wierda
President & CEO
$16K
4 hrs/wk
Richard Evans
Director
—
1 hrs/wk
Louis Katopodis
Director
—
1 hrs/wk
Diane Lee Kraitman
Director
—
1 hrs/wk
Michael J Keating
Founding Director
—
2 hrs/wk
Robert Nichols
Director
—
1 hrs/wk
William Plunkett
Director
—
1 hrs/wk
Martin Raber
Director
—
1 hrs/wk
Steve Winfield
Director
—
1 hrs/wk
Richard Marschner
Director
—
1 hrs/wk
Phyllis Cohen
Director
—
1 hrs/wk
Grants received
Showing 62 of 62
Funded by
$6.9M from 20 funders · 62 grants · 2017–2024
$5M · 3 grants · 2020–2023
$925K · 4 grants · 2019–2023
$344K · 8 grants · 2017–2023
$197K · 6 grants · 2018–2024
$165K · 4 grants · 2017–2023
$50K · 1 grant · 2022
$40K · 6 grants · 2018–2024
$37K · 4 grants · 2021–2024